MEDIGENE AG NA O.N./ DE000A1X3W00 /
| 2024-04-19 9:08:42 PM | Chg. -0.05 | Volume | Bid9:58:00 PM | Ask9:58:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.91EUR | -2.30% | 20,600 Turnover: 39,792.25 |
1.87Bid Size: 900 | 1.97Ask Size: 2,100 | 47.16 mill.EUR | 0.00% | - |
Assets
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | .4000 | 1 | 2.5000 | 3.3000 | 4.3000 | ||||||
| Intangible Assets | 27 | 36.2000 | 33.5000 | 33.6000 | 34.1000 | ||||||
| Long-Term Investments | 6.4000 | 7 | 13 | 5.9000 | 5.7000 | ||||||
| Fixed Assets | 36.4000 | 46.6000 | 51.6000 | 47.7000 | 48.6000 | ||||||
| Inventories | 3 | 4.4000 | 6.7000 | 7.9000 | 7.7000 | ||||||
| Accounts Receivable | - | - | - | - | - | ||||||
| Cash and Cash Equivalents | 10.2000 | 15 | 8.8000 | 14.6000 | 27.7000 | ||||||
| Current Assets | 16.3000 | 24.7000 | 59.9000 | 64 | 63.3000 | ||||||
| Total Assets | 52.7000 | 71.3000 | 113.5000 | 111.7000 | 111.9000 | ||||||
Liabilities
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.4000 | 1.8000 | 1.4000 | 1 | .7000 | ||||||
| Long-term debt | 10.6000 | 11.5000 | 11 | 9.7000 | 7.6000 | ||||||
| Liabilities to Banks | 14.3000 | 17.4000 | 18.9000 | 16.9000 | 12.4000 | ||||||
| Provisions | - | 2.4000 | 2 | 1.6000 | 2.2000 | ||||||
| Liabilities | 16.4000 | 22.2000 | 23.5000 | 33.1000 | 25.8000 | ||||||
| Share Capital | 9.8720 | 13.9270 | 19.6780 | 20.1370 | 22.3010 | ||||||
| Total Equity | 36.3000 | 49.1000 | 90 | 78.6000 | 86.2000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 52.7000 | 71.3000 | 113.5000 | 111.7000 | 111.9000 | ||||||
Income Statement
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 4.2000 | 5.2000 | 3.1000 | 4.1000 | 7.7000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -9 | -2.9000 | -10.4000 | -13.2000 | -13.4000 | ||||||
| Interest Income | -1.6000 | -1.7700 | -2.9400 | -1 | -1.4000 | ||||||
| Income Before Taxes | -10.3000 | -5.9000 | -13.4000 | -9.7000 | -12.9000 | ||||||
| Income Taxes | 0.0000 | -.2000 | -.4000 | -.2000 | .6000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -10.3000 | -5.8000 | -13 | -9.5000 | -13.6000 | ||||||
Per Share
Cash Flow
| 2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -12.3000 | -8.8000 | -10.6000 | -3.8000 | -20.8000 | ||||||
| Cash Flow from Investing Activities | -.1000 | -.9000 | -39.4000 | 9.9000 | 15.2000 | ||||||
| Cash Flow from Financing | 2.4000 | 14.5000 | 43.8000 | -.2000 | 18.7000 | ||||||
| Decrease / Increase in Cash | -10 | 4.8000 | -6.2000 | 5.9000 | 13.1000 | ||||||
| Employees | 51 | 72 | 73 | 88 | 91 | ||||||
